Comparative genomic sequence analysis of the human and mouse cystic fibrosis transmembrane conductance regulator genes.

The identification of the cystic fibrosis transmembrane conductance regulator gene (CFTR) in 1989 represents a landmark accomplishment in human genetics. Since that time, there have been numerous advances in elucidating the function of the encoded protein and the physiological basis of cystic fibrosis. However, numerous areas of cystic fibrosis biology require additional investigation, some of which would be facilitated by information about the long-range sequence context of the CFTR gene. For example, the latter might provide clues about the sequence elements responsible for the temporal and spatial regulation of CFTR expression. We thus sought to establish the sequence of the chromosomal segments encompassing the human CFTR and mouse Cftr genes, with the hope of identifying conserved regions of biologic interest by sequence comparison. Bacterial clone-based physical maps of the relevant human and mouse genomic regions were constructed, and minimally overlapping sets of clones were selected and sequenced, eventually yielding approximately 1.6 Mb and approximately 358 kb of contiguous human and mouse sequence, respectively. These efforts have produced the complete sequence of the approximately 189-kb and approximately 152-kb segments containing the human CFTR and mouse Cftr genes, respectively, as well as significant amounts of flanking DNA. Analyses of the resulting data provide insights about the organization of the CFTR/Cftr genes and potential sequence elements regulating their expression. Furthermore, the generated sequence reveals the precise architecture of genes residing near CFTR/Cftr, including one known gene (WNT2/Wnt2) and two previously unknown genes that immediately flank CFTR/Cftr.

[1]  F. Collins,et al.  New goals for the U.S. Human Genome Project: 1998-2003. , 1998, Science.

[2]  P Stanier,et al.  Isolation of a human gene with protein sequence similarity to human and murine int‐1 and the Drosophila segment polarity mutant wingless. , 1988, The EMBO journal.

[3]  R. Wilson,et al.  High throughput fingerprint analysis of large-insert clones. , 1997, Genome research.

[4]  E. Green,et al.  Sequence-tagged site (STS) content mapping of human chromosomes: theoretical considerations and early experiences. , 1991, PCR methods and applications.

[5]  B. Aronow,et al.  Genomic sequence comparison of the human and mouse adenosine deaminase gene regions , 1999, Mammalian Genome.

[6]  H. Heng,et al.  Fluorescence in situ hybridization mapping of the cystic fibrosis transmembrane conductance regulator (CFTR) gene to 7q31.3. , 1993, Cytogenetics and cell genetics.

[7]  Wendy L. Kimber,et al.  Cystic fibrosis in the mouse by targeted insertional mutagenesis , 1992, Nature.

[8]  B. Ramsey,et al.  Management of pulmonary disease in patients with cystic fibrosis. , 1996, The New England journal of medicine.

[9]  M. Walsh,et al.  Transcription of Cystic Fibrosis Transmembrane Conductance Regulator Requires a CCAAT-like Element for both Basal and cAMP-mediated Regulation * , 1995, The Journal of Biological Chemistry.

[10]  L. J. Maher,et al.  Enzymatic and chemical probing of an S1 nuclease-sensitive site upstream from the human CFTR gene. , 1994, Gene.

[11]  M. Hollingsworth,et al.  A Regulatory Element in Intron 1 of the Cystic Fibrosis Transmembrane Conductance Regulator Gene (*) , 1996, The Journal of Biological Chemistry.

[12]  R. Crystal,et al.  The cystic fibrosis gene has a "housekeeping"-type promoter and is expressed at low levels in cells of epithelial origin. , 1991, The Journal of biological chemistry.

[13]  L. Tsui,et al.  Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. , 1991, Genomics.

[14]  F. Collins,et al.  Characterization of the cystic fibrosis transmembrane conductance regulator promoter region. Chromatin context and tissue-specificity. , 1993, The Journal of biological chemistry.

[15]  A. Harris,et al.  In Vivo Analysis of DNase I Hypersensitive Sites in the Human CFTR Gene , 1999, Molecular medicine.

[16]  R. Gibbs,et al.  Large-scale comparative sequence analysis of the human and murine Bruton's tyrosine kinase loci reveals conserved regulatory domains. , 1997, Genome research.

[17]  T. Hagemann Cystic fibrosis-drug therapy. , 1996, Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners.

[18]  R. Quatrano Genomics , 1998, Plant Cell.

[19]  M. Welsh,et al.  Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis , 1993, Cell.

[20]  C. Higgins,et al.  Immunocytochemical localization of the cystic fibrosis gene product CFTR. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Olson,et al.  Chromosomal region of the cystic fibrosis gene in yeast artificial chromosomes: a model for human genome mapping. , 1990, Science.

[22]  W Miller,et al.  Comparative sequence analysis of the mouse and human Lgn1/SMA interval. , 1999, Genomics.

[23]  L. Tsui,et al.  Characterization of the promoter region of the cystic fibrosis transmembrane conductance regulator gene. , 1991, The Journal of biological chemistry.

[24]  W Miller,et al.  Comparative sequence of human and mouse BAC clones from the mnd2 region of chromosome 2p13. , 1999, Genome research.

[25]  M. Guyer,et al.  Assessing the quality of the DNA sequence from the Human Genome Project. , 1999, Genome research.

[26]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[27]  W. Miller,et al.  Long human-mouse sequence alignments reveal novel regulatory elements: a reason to sequence the mouse genome. , 1997, Genome research.

[28]  R. Boucher,et al.  Status of gene therapy for cystic fibrosis lung disease. , 1999, The Journal of clinical investigation.

[29]  R. Fulton,et al.  A physical map of human chromosome 7: an integrated YAC contig map with average STS spacing of 79 kb. , 1997, Genome research.

[30]  R. Williamson,et al.  Cystic fibrosis mouse with intestinal obstruction , 1992, The Lancet.

[31]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA , 1989, Science.

[32]  R. Schutgens The metabolic and molecular bases of inherited disease, seventh edition—3-volume set Edited by Charles R. Scriver, Arthur L. Beaudet, William S. Sly, and David Valle. New York, McGraw-Hill, 1995, $285.84 (xxxvi + 4605 pages and 93-page index), ISBN 0-07909-826-6 , 1995, Trends in Endocrinology & Metabolism.

[33]  Ronald G. Crystal,et al.  Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA , 1993, Nature Genetics.

[34]  R. Idzerda,et al.  Basal expression of the cystic fibrosis transmembrane conductance regulator gene is dependent on protein kinase A activity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Andrew Smith Genome sequence of the nematode C-elegans: A platform for investigating biology , 1998 .

[36]  B. Koller,et al.  An Animal Model for Cystic Fibrosis Made by Gene Targeting , 1992, Science.

[37]  J. Riordan,et al.  Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR) , 1992, Cell.

[38]  F. Collins,et al.  Positional cloning: Let's not call it reverse anymore , 1992, Nature Genetics.

[39]  R. Gibbs,et al.  Comparative sequence analysis of a gene-rich cluster at human chromosome 12p13 and its syntenic region in mouse chromosome 6. , 1998, Genome research.

[40]  P Green,et al.  Base-calling of automated sequencer traces using phred. II. Error probabilities. , 1998, Genome research.

[41]  D. Cox,et al.  An action plan for mouse genomics , 1999, Nature Genetics.

[42]  L. Tsui,et al.  Molecular cloning and sequence analysis of the murine cDNA for the cystic fibrosis transmembrane conductance regulator. , 1991, Genomics.

[43]  E. Denamur,et al.  Analysis of the mouse and rat CFTR promoter regions. , 1994, Human molecular genetics.

[44]  A. Harris,et al.  Towards an ovine model of cystic fibrosis. , 1997, Human molecular genetics.

[45]  A. Harris,et al.  Characterization of DNASE I hypersensitive sites in the 120kb 5' to the CFTR gene. , 1995, Biochemical and biophysical research communications.

[46]  E. Denamur,et al.  Cross-species characterization of the promoter region of the cystic fibrosis transmembrane conductance regulator gene reveals multiple levels of regulation. , 1997, The Biochemical journal.

[47]  Francis S. Collins,et al.  Positional cloning moves from perditional to traditional , 1995, Nature Genetics.

[48]  Webb Miller,et al.  A space-efficient algorithm for local similarities , 1990, Comput. Appl. Biosci..

[49]  G. McKnight,et al.  Characterization of the cAMP Response Element of the Cystic Fibrosis Transmembrane Conductance Regulator Gene Promoter* , 1996, The Journal of Biological Chemistry.

[50]  E. Schwiebert,et al.  Functional human CFTR produced by stable Chinese hamster ovary cell lines derived using yeast artificial chromosomes. , 1997, Human molecular genetics.

[51]  P. Green,et al.  Base-calling of automated sequencer traces using phred. I. Accuracy assessment. , 1998, Genome research.

[52]  Matthew P. Anderson,et al.  Cystic fibrosis transmembrane conductance regulator: A chloride channel with novel regulation , 1992, Neuron.

[53]  J. Riordan Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein. , 1999, American journal of human genetics.

[54]  R C Hardison,et al.  Software tools for analyzing pairwise alignments of long sequences. , 1991, Nucleic acids research.

[55]  V. Sheffield,et al.  The CMT2D locus: refined genetic position and construction of a bacterial clone-based physical map. , 1999, Genome research.

[56]  Stephen M. Mount,et al.  A catalogue of splice junction sequences. , 1982, Nucleic acids research.

[57]  P. Green,et al.  Consed: a graphical tool for sequence finishing. , 1998, Genome research.

[58]  Elaine R. Mardis,et al.  In Genome analysis: A laboratory manual , 1997 .

[59]  P. Scambler,et al.  Cloning the mouse homolog of the human cystic fibrosis transmembrane conductance regulator gene. , 1991, Genomics.

[60]  L. Tsui,et al.  Identification of the cystic fibrosis gene: chromosome walking and jumping. , 1989, Science.

[61]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Genetic Analysis , 1989, Science.

[62]  E. Green,et al.  Construction of a high-resolution physical map of the approximate 1-Mb region of human chromosome 7q31.1-q31.2 harboring a putative tumor suppressor gene. , 1999, Neoplasia.

[63]  Richard C. Boucher,et al.  Defective Epithelial Chloride Transport in a Gene-Targeted Mouse Model of Cystic Fibrosis , 1992, Science.

[64]  S. Karlin,et al.  Prediction of complete gene structures in human genomic DNA. , 1997, Journal of molecular biology.

[65]  L. Hood,et al.  Striking sequence similarity over almost 100 kilobases of human and mouse T–cell receptor DNA , 1994, Nature Genetics.

[66]  E. Denamur,et al.  Methylation status of CpG sites in the mouse and human CFTR promoters. , 1995, DNA and cell biology.